Repligen | RGEN - Ebitda





Ebitda 変化する 日付
Agilent USD 577M 77M 2026-06
Align Technology USD 232.86M 3.72M 2026-06
Bio Techne USD 115.94M 763K 2026-06
BioMarin Pharmaceutical USD 222.32M 76.27M 2026-06
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Bruker USD 143.2M 33.2M 2026-06
Charles River Laboratories USD 298.04M 25.1M 2026-09
Danaher USD 2.1B 257M 2026-09
Dentsply International USD 146M 44M 2026-09
General Electric Aerospace USD 3.32B 265M 2026-09
Henry Schein USD 321M 33M 2026-09
Illumina USD 330M 80M 2026-06
IQVIA Holdings USD 1.03B 38M 2026-09
Mettler Toledo International USD 366.1M 43.45M 2026-09
Myriad Genetics USD 14.3M 4M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Pfizer USD 6.36B 350M 2026-09
Repligen USD 43.84M 70K 2026-09
Revvity USD 227.55M 629K 2026-09
Standard Biotools USD -6.56M 1.45M 2026-06
Thermo Fisher Scientific USD 3.79B 244M 2026-09
Waters USD 554M 158M 2026-09
West Pharmaceutical Services USD 267.4M 23.8M 2026-09